English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17938/22957 (78%)
Visitors : 7399174      Online Users : 298
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/24242


    Title: SAFETY OF BELIMUMAB IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: YEAR 2 FOLLOW-UP OF A LARGE PHASE 4, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Authors: Sheikh, S;Scheinberg, M;Wei, JCC;Tegzova, D;Stohl, W;Mucenic, T;Punwaney, R;Kurrasch, R;Harris, J;Muzaffar, S;Fernandes, S;Fox, NL;Liu, A;Quasny, H;Roth, D
    Date: 2021
    Issue Date: 2022-08-05T10:45:22Z (UTC)
    Publisher: BMJ PUBLISHING GROUP
    ISSN: 0003-4967
    URI: http://dx.doi.org/10.1136/annrheumdis-2021-eular.2552
    https://www.webofscience.com/wos/woscc/full-record/WOS:000692625300288
    https://ir.csmu.edu.tw:8080/handle/310902500/24242
    Relation: ANNALS OF THE RHEUMATIC DISEASES ,2021 ,v80 ,p1171-1171
    Appears in Collections:[中山醫學大學研究成果] 其他文獻

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML183View/Open


    SFX Query

    All items in CSMUIR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback